Skip to main content

Month: July 2020

Northland Announces Its Second Quarter 2020 Financial Results Release Date and Provides Investor Call and Webcast Details

TORONTO, July 13, 2020 (GLOBE NEWSWIRE) — Northland Power Inc. (“Northland”) (TSX: NPI) announces it will release its 2020 second quarter financial results after market close on Wednesday, August 12, 2020. Northland’s management will hold an investor conference call and webcast at 10 a.m. Eastern Time (ET) on Thursday, August 13, 2020, followed by a question and answer period.Conference call details:The call will also be broadcast live on the internet, in listen-only mode and may be accessed on northlandpower.com.For those unable to attend the live call, an audio recording will be available on Northland’s website at northlandpower.com on August 14, 2020.ABOUT NORTHLAND POWERNorthland is a global developer, owner and operator of sustainable infrastructure assets that deliver predictable cash flows. Headquartered in Toronto,...

Continue reading

nCino Announces Pricing of Initial Public Offering

WILMINGTON, N.C., July 13, 2020 (GLOBE NEWSWIRE) — nCino, Inc. (“nCino”) today announced the pricing of its initial public offering of 8,060,000 shares of its common stock at the initial public offering price of $31.00 per share. The underwriters have been granted a 30-day option to purchase up to 1,209,000 additional shares at the initial public offering price less underwriting discounts and commissions. The shares are expected to begin trading on The Nasdaq Global Select Market on July 14, 2020, under the ticker symbol “NCNO.” The offering is expected to close on July 16, 2020, subject to customary closing conditions.BofA Securities and Barclays are acting as lead book-running managers for the offering. KeyBanc Capital Markets and SunTrust Robinson Humphrey are also acting as book-running managers for the offering, along with Piper...

Continue reading

Dealnet Urges Dissidents to Stop Misleading Shareholders

TORONTO, July 13, 2020 (GLOBE NEWSWIRE) — Dealnet Capital Corp. (“Dealnet” or the “Company”) (TSX VENTURE: DLS) warns shareholders about continued misleading statements from a group of dissident shareholders, led by Steven Small (“Small”) of Capital Partners. The Company’s Board and Management team remain focused on operating Dealnet and creating value for all shareholders and have not responded to every misstatement from Small and the dissident shareholders, but feel a responsibility to alert shareholders to not rely on the dissident communications for investment decisions. To cite but a few examples:Small stated “massive defaults and deferrals loom” in a May 28, 2020 press release. When the Q2 results are released by the Company, they will show that Small’s assertion was inaccurate given that delinquencies as of June 30, 2020...

Continue reading

Galera Therapeutics Completes Enrollment of Phase 1b/2a Clinical Trial of GC4419 in Combination with Radiotherapy for Locally Advanced Pancreatic Cancer

MALVERN, Pa., July 13, 2020 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary small molecule therapeutics that have the potential to transform radiotherapy in cancer, today announced that it has completed patient enrollment in its pilot Phase 1b/2a safety and anti-cancer efficacy clinical trial of avasopasem manganese (GC4419) in combination with stereotactic body radiation therapy (SBRT) in patients with locally advanced pancreatic cancer (LAPC).Galera’s investigational, highly selective small molecule superoxide dismutase (SOD) mimetics are designed to rapidly and selectively convert superoxide to hydrogen peroxide and oxygen. These dismutase mimetics have potential anti-cancer synergy supported by positive...

Continue reading

Cristiano Veloso Acquires Securities of Verde AgriTech Plc

BELO HORIZONTE, Brazil, July 13, 2020 (GLOBE NEWSWIRE) — Cristiano Veloso (the “Acquiror”) announces that he acquired 750,000 shares (the “Shares”) of Verde AgriTech Plc (TSX: “NPK”) (OTCQB: “AMHPF”) (the “Company”) on the exercise of stock options (the “Issuance”), on July 10, 2020. Prior to the Issuance, The Acquiror held 7,846,339 Shares representing approximately 16.49% of the issued and outstanding Shares. Following the Issuance, The Acquiror holds 8,596,339 Shares representing approximately 17.75% of the issued and outstanding Shares. The Acquiror received the Issuance shares at $0.425 per Share for total consideration of $318,750. The Acquiror acquired the Shares for investment purposes, and the Acquiror may, depending upon market and other conditions, increase or decrease his beneficial ownership, control or...

Continue reading

Parkland Corporation Announces July 2020 Dividend

CALGARY, Alberta, July 13, 2020 (GLOBE NEWSWIRE) — Parkland Corporation (“Parkland”) (TSX:PKI) announces that a dividend of $0.1012 per share will be paid on August 14, 2020 to shareholders of record on July 22, 2020. The dividend will be an ‘eligible dividend’ for Canadian income tax purposes. The ex-dividend date is July 21, 2020.Enhanced Dividend Reinvestment PlanParkland’s enhanced Dividend Reinvestment Plan (“Enhanced DRIP”) allows shareholders to reinvest their cash dividends to purchase additional Parkland shares from treasury at a 5% per share discount to the average of the daily volume weighted average trading prices during the Pricing Period. For further details on the Enhanced DRIP and the Pricing Period, please visit www.parkland.ca/en/investors/dividends.Shareholders who wish to enroll...

Continue reading

FutureFuel to Release Second Quarter Financial Results on August 7, 2020

Clayton, Mo., July 13, 2020 (GLOBE NEWSWIRE) —  FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, announced today that it will release second quarter 2020 financial results after market close on Friday, August 7, 2020.About FutureFuelFutureFuel is a leading manufacturer of diversified chemical products and biofuels. FutureFuel’s chemicals segment manufactures specialty chemicals for specific customers (“custom manufacturing”) as well as multi-customer specialty chemicals (“performance chemicals”). FutureFuel’s custom manufacturing product portfolio includes proprietary agrochemicals, adhesion promoters, a biocide intermediate, and an antioxidant precursor. FutureFuel’s performance chemicals products include a portfolio of proprietary nylon and polyester polymer modifiers...

Continue reading

Medley Capital Corporation Announces One-for-Twenty Reverse Stock Split; Common Stock to Begin Trading on a Split-Adjusted Basis at Market Open on July 27, 2020

NEW YORK, July 13, 2020 (GLOBE NEWSWIRE) — Medley Capital Corporation (NYSE: MCC) (TASE: MCC) (the “Company”) announced today that, following the Company’s 2020 Annual Meeting of Stockholders  held on June 30, 2020 (the “Annual Meeting”), on July 7, 2020, the Company’s board of directors (the “Board”) determined that it is in the best interests of the Company and its stockholders to effect a reverse stock split of its common stock, par value $0.001 (the “Common Stock”), of 1-20 (the “Reverse Stock Split”) and reduce the number of authorized shares of Common stock by the reverse stock split ratio (the “Authorized Share Reduction”). Accordingly, on July 13, 2020, the Company filed a Certificate of Amendment (the “Certificate of Amendment”) to the Certificate of Incorporation with the Secretary of State of the State of Delaware to effect...

Continue reading

Firm Capital Mortgage Investment Corporation Announces July 2020 Dividend

TORONTO, July 13, 2020 (GLOBE NEWSWIRE) — Firm Capital Mortgage Investment Corporation (the “Corporation”) (TSX: FC) is pleased to announce that its board of directors has declared a monthly cash dividend of $0.078 per common share (subject to adjustment in the discretion of the board of directors) payable on the date set out below to holders of common shares of record at the close of business on the record date set out below:The Corporation has in place a Dividend Reinvestment Plan (“DRIP”) and Share Purchase Plan (“Plan”) that is available to its shareholders. Shareholders are reminded that they can participate in the Corporation’s Dividend Reinvestment Plan and Share Purchase Plan. Participant shareholders pay no commission for common shares issued from treasury.DIVIDEND REINVESTMENT PLAN (DRIP)The DRIP allows participants...

Continue reading

Prestige Consumer Healthcare Inc. to Release Fiscal 2021 First Quarter Earnings Results

TARRYTOWN, N.Y., July 13, 2020 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 first quarter earnings release on Thursday, August 6, 2020 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.To participate via phone listeners calling from the U.S. and Canada may dial 844-233-9440, or 574-990-1016 internationally, using the conference ID 4482198. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com.Telephonic replays will be available for approximately one week following completion of the live call and can be accessed at 855-859-2056 within North America, and at 404-537-3406...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.